Revolution Medicines Gets FDA Breakthrough Designation for Cancer Treatment
By Katherine HamiltonRevolution Medicines received breakthrough therapy designation from the Food and Drug Administration for its treatment of pancreatic cancer.The designation is for Rasonque to treat metastatic pancreatic adenocarcinoma (PDAC), a form of pancreatic cancer, in combination with gem…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.